Connect with us

Technology

World Energy GH2 and the Government of Canada sign definitive agreement to develop green hydrogen project

Published

on

Newfoundland and Labrador cements its spot as a leading jurisdiction in the clean energy transition

OTTAWA, ON, Feb. 28, 2024 /CNW/ – The Honourable Seamus O’Regan, Canada’s Minister of Labour and Seniors, today announced, on behalf of the Honourable Mary Ng, Minister of Export Promotion, International Trade and Economic Development, federal government support for Canada’s first commercial-scale green hydrogen / ammonia facility on the west coast of Newfoundland and Labrador. Export Development Canada (EDC), on behalf of the Government of Canada, and World Energy GH2 have signed definitive agreements in connection with a CA$128M (US$95M) credit facility to support the development of Project Nujio’qonik through to its financial close of its long-term financing.

Newfoundland and Labrador cements its spot as a leading jurisdiction in the clean energy transition

The credit facility will help finance the build out of clean power generation and clean hydrogen production that will advance Canada’s efforts and initiatives in pursuit of global decarbonization. The agreement demonstrates Canada’s continuing material support of the Canada-Germany Hydrogen Alliance signed between the two countries at Project Nujio’qonik’s site in Stephenville, NL, in August 2022, and provides leadership for renewable green energy to be generated and exported to markets in Germany, Europe and around the world, as well as for domestic consumption.

Once complete, Project Nujio’qonik will produce ~210,000 tonnes of green hydrogen per year (1.2 million tonnes of green ammonia) with the first phase expected to produce ~400,000 tonnes of green ammonia for export. Project Nujio’qonik’s green hydrogen and ammonia will be RFNBO-compliant (renewable fuels of non-biological origin), and will meet Europe’s criteria for green hydrogen.

Project Nujio’qonik’s first phase will create approximately 2,200 direct construction jobs, 400 operations jobs, and 4,200 indirect jobs.

“World Energy GH2 thanks EDC and the Government of Canada for its support in helping launch the green hydrogen industry here in Newfoundland and Labrador,” said Sean Leet, Managing Director and CEO, World Energy GH2. “This commitment from the federal government reflects the confidence we’ve built in Project Nujio’qonik, both here in Canada and internationally. By consistently achieving key de-risking milestones, we’ve confirmed that Project Nujio’qonik is one of the leading, commercial-scale green hydrogen projects in the world.”

Richard Hugh, CFO, World Energy GH2, further commented: “Charting and navigating new waters is never an easy undertaking, but our colleagues at EDC, and all levels of the federal and NL provincial governments, have collaborated with us tirelessly to help make this inaugural agreement a defining moment for Canada and the province of Newfoundland and Labrador.”

“Project Njuio’qonik will surpass the highest global standards for emissions and sustainability, and is poised to deliver against Europe’s ambitious RePowerEU targets for green hydrogen,” said John Risley, Chair, World Energy GH2. “Meeting those targets will require continued, decisive action by the European Commission and its member states. We thank the federal government for their leadership and commitment to moving Canada forward as a leader in the global energy transition.”

Kyung-il Park, President and CEO of SK ecoplant, which is an investor in Project Nujio’qonik, expressed his gratitude for the federal government’s commitment, saying: “Thanks to this commitment from the federal government, we expect our project to move more quickly into the next phase, such as FEED execution and long-lead item orders, which will be of great help in achieving our goal of being the first commercial green hydrogen / ammonia producer in Canada.”

“We are committed to reaching net-zero emissions by 2050 by prioritizing clean technology and energy leadership in Canada,” said The Honourable Mary Ng, Minister of Export Promotion, International Trade and Economic Development. “This involves emphasizing innovation, creating green jobs, and supporting projects like the World Energy GH2 initiative.”

The Honourable Seamus O’Regan, Minister of Labour and Seniors, and Member of Parliament, St. John’s South—Mount Pearl, Newfoundland and Labrador, Government of Canada, commented: “Newfoundland and Labrador will be a global leader in clean energy. It will be the workers of our Province who will sell hydrogen to the world and take home the profits. That’s because of companies like World Energy GH2 and the workers who will make it happen.”

The Honourable Gudie Hutchings, Minister of Rural Economic Development, Minister responsible for the Atlantic Canada Opportunities Agency, and Member of Parliament, Long Range Mountains, Newfoundland and Labrador, Government of Canada, commented: “Newfoundland and Labrador has the resources, the workers and the passion to lead the way to power Canada’s renewable energy future. Working with partners like World Energy GH2, we will get there.”

Project Nujio’qonik milestones:

June 2022: Environmental Registration August 23, 2022: Canada – Germany Hydrogen Alliance signed at the Project Nujio’qonik site in Stephenville, Newfoundland and Labrador (NL)September 2022: MOUs signed with Qalipu First Nation and the Town of StephenvilleNovember 2022: Wind measurement campaign launchedMarch 2023: Crown lands bid submittedMay 2023: SK ecoplant invested USD $50M in Project Nujio’qonikJune 2023: World Energy GH2 acquired the Port of StephenvilleJuly 2023: Pre-FEED (front-end engineering design) completedAugust 2023: Environmental Impact Statement (EIS) submittedAugust 2023: Crown lands secured ~108,000 ha (~266,000 acres)September 2023: Scholarships for College of the North Atlantic’s green energy programs announcedDecember 2023: One year of wind data achievedJanuary 2024: First North American member of the ENERGY HUB Port of Wilhemshaven, GermanyJanuary 2024: Environmental Impact Statement (EIS) Amendment submittedFebruary 2024: Export Development Canada (EDC), on behalf of the Government of Canada, signs a definitive agreement in connection with C$128M (US$95M) credit facility

Advisors

RBC Capital Markets and Green Giraffe Advisory are acting as financial advisors for the credit facility on behalf of World Energy GH2. McCarthy Tétrault and McInnes Cooper are acting as legal advisors to World Energy GH2.

Norton Rose Fulbright Canada LLP and Stewart McKelvey are acting as legal advisors on the transaction.

About World Energy GH2

World Energy GH2 is a Newfoundland and Labrador-based renewable energy partnership affiliated with World Energy LLC, one of the world’s largest producers of green fuels. Project Nujio’qonik is a consortium of partners advancing a cost-effective wind power-to-green hydrogen/ammonia production facility to be located on the west coast of the province of Newfoundland and Labrador, Canada. Project Nujio’qonik aims to be Canada’s first commercial green hydrogen/ammonia producer created from 3+ Gigawatts of wind energy in one of the world’s best wind resource regions. Project Nujio’qonik’s partners are CFFI Ventures, Columbus Capital, World Energy LLC, Horizon Maritime, and SK ecoplant. https://worldenergygh2.com/ 

About SK ecoplant 

SK ecoplant is the environment and energy arm of SK Group, leading the group’s future ESG business as a global environmental and energy company. By integrating AI and digital transformation into its entire value chain of the environmental business, SK ecoplant is upgrading its business and accelerating expansion of its operation to the global market from its global operation base in Southeast Asia. The company has grown rapidly in the waste battery recycling sector and renewable energy sectors, including hydrogen, fuel cells, offshore wind power and photovoltaic power. It is also committed to ESG-oriented management for sustainable growth, leading the efforts to solve global environmental and energy issues and achieve a circular economy for zero waste and net zero. http://www.skecoplant.com 

SOURCE World Energy GH2

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Baidu to Report First Quarter 2026 Financial Results on May 18, 2026

Published

on

By

BEIJING, April 23, 2026 /PRNewswire/ — Baidu, Inc. (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) (“Baidu” or the “Company”), a leading AI company with strong Internet foundation, today announced that it will report its financial results for the First Quarter 2026 ended March 31, 2026, before the U.S. market opens on May 18, 2026. Baidu’s management will hold an earnings conference call at 8:00 AM on May 18, 2026, U.S. Eastern Time (8:00 PM on May 18, 2026, Beijing Time).

Please register in advance of the conference call using the link provided below. It will automatically direct you to the registration page of “Baidu Inc. Q1 2026 Earnings Conference Call”. Please follow the steps to enter your registration details, then click “Register”. Upon registering, you will then be provided with the dial-in number, the passcode, and your unique access PIN. This information will also be emailed to you as a calendar invite.

For pre-registration, please click:
https://s1.c-conf.com/diamondpass/10054331-iu876y.html

In the 10 minutes prior to the call start time, you may use the conference access information (including dial-in number(s), the passcode and unique access PIN) provided in the calendar invite that you have received following your pre-registration.

Additionally, a live and archived webcast of this conference call will be available at https://ir.baidu.com.

A replay of the conference call may be accessed by phone at the following number until May 25, 2026:
US: 1 855 883 1031
Reply PIN: 10054331

About Baidu

Founded in 2000, Baidu’s mission is to make the complicated world simpler through technology. Baidu is a leading AI company with strong Internet foundation, trading on Nasdaq under “BIDU” and the HKEX under “9888.” One Baidu ADS represents eight Class A ordinary shares.

View original content:https://www.prnewswire.com/news-releases/baidu-to-report-first-quarter-2026-financial-results-on-may-18-2026-302751204.html

SOURCE Baidu, Inc.

Continue Reading

Technology

Phase 1 of 139th Canton Fair Introduces New Dedicated Product Zones as Emerging Technologies Take Center Stage

Published

on

By

GUANGZHOU, China, April 23, 2026 /PRNewswire/ — The 139th China Import and Export Fair (Canton Fair) has further optimized its exhibition landscape with nine new dedicated product zones, reflecting ongoing structural shifts in global trade and the continued upgrading of China’s export portfolio.

Among the most closely watched additions in Phase 1 are the consumer and agricultural drone zones, both making their debut at the Canton Fair and offering a focused showcase of applications in the low‑altitude economy. The consumer drone zone showcases progress in flight control, AI‑based obstacle avoidance and energy efficiency across imaging, tourism, emergency response and patrol. The agricultural drone zone highlights precision farming, with spraying, seeding and field‑management demonstrations showing terrain‑following, intelligent route planning, and precise payload control.

On day one, a Shandong‑based drone manufacturer welcomed buyers from 30+ countries, with over 50 strong leads. One buyer, after seeing load and wind‑resistance demonstrations, immediately confirmed three sample units and even proposed becoming a regional distributor.

Display technology is another focal point of Phase 1, highlighting advances in color accuracy, energy efficiency, and overall visual performance. Developments in fine‑grained control, expanded color gamut, and reduced power consumption point to a clear trend toward immersive viewing experiences combined with sustainability gains.

The smart wearables zone underscores how intelligent devices are becoming key interfaces for human‑machine interaction. From real‑time language translation and adaptive noise cancellation to long‑term health monitoring and AI‑enabled eyewear, wearables are evolving from standalone products into integrated systems that support communication, well‑being, and productivity across daily and professional settings.

The service robots zone further illustrates how artificial intelligence is moving from conceptual exploration to large‑scale deployment. Advanced robots showcased across industrial, commercial, medical, and public‑service scenarios demonstrate growing autonomy, multi‑sensory perception, and closer human-robot collaboration.

By bringing emerging technologies into clearer focus through dedicated zones, the 139th Canton Fair is reinforcing its function as a platform where trade trends take shape, innovation meets application, and global buyers gain early insights into cutting-edge technologies.

For pre-registration, please click: https://buyer.cantonfair.org.cn/register/buyer/email?source_type=16

Photo – https://mma.prnewswire.com/media/2963958/1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/phase-1-of-139th-canton-fair-introduces-new-dedicated-product-zones-as-emerging-technologies-take-center-stage-302751520.html

Continue Reading

Technology

OZMOSI Announces Strategic Partnership with Planview to Advance AI-Driven Planning in Pharmaceutical R&D

Published

on

By

By combining structured clinical intelligence with AI-driven portfolio planning, the partnership gives pharmaceutical teams a faster, clearer way to make high-stakes R&D decisions

SPRING LAKE HEIGHTS, N.J., April 23, 2026 /PRNewswire/ — OZMOSI, a leading provider of structured pharmaceutical development intelligence, today announced a strategic partnership with Planview, the leading AI-powered end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD).

By integrating OZMOSI’s machine-readable clinical datasets directly into Planview’s AI-driven portfolio planning platform, external scientific data is now connected to internal R&D planning in one system,  helping pharmaceutical organizations better predict market shifts, prioritize R&D investments, and make faster, more confident decisions.

This integration brings external clinical reality into internal R&D decision-making, so teams can plan based on what’s actually happening, not just on what they hope will happen.

The two organizations combine deep expertise in complementary areas, united by a shared focus on improving the quality and usability of data for strategic decision-making. OZMOSI provides structured, machine-readable intelligence across clinical trials, drug development programs, regulatory activity, and scientific literature, built on a consistent taxonomy that standardizes how data is connected and understood. Planview’s platform enables organizations to model complex investment scenarios, align initiatives with corporate strategy, and optimize resource allocation.

Together, these capabilities give teams a clearer, more complete view of the R&D landscape, grounded in clean, standardized data and strengthened by AI-driven analysis.

“AI is only as powerful as the data that fuels it,” said Beau Bush, President and Founder of OZMOSI. “Pharmaceutical organizations have no shortage of data, but too often it’s fragmented, inconsistent, and difficult to operationalize. By bringing OZMOSI’s structured data foundation together with Planview’s AI-driven planning capabilities, we’re enabling teams to move beyond disconnected analysis and toward truly integrated, forward-looking decision-making.”

“Strategic planning in pharmaceutical R&D is becoming increasingly dependent on advanced analytics and AI,” said  Louise Allen, Chief Product Officer at Planview. “Integrating OZMOSI’s clinical intelligence into Planview’s platform enables pharmaceutical leaders to make better decisions by combining trusted external data with AI-driven planning

OZMOSI’s dataset spans more than 800,000 clinical trials, over 35,000 drugs, and 4,000 diseases and conditions. It brings together insights from clinical trial registries, regulatory filings, scientific literature, company disclosures, and industry announcements into a unified, structured dataset.

When integrated into Planview’s platform, this intelligence enables pharmaceutical and biotech organizations to evaluate competitive landscapes, identify emerging clinical trends, and simulate portfolio outcomes with unprecedented precision.

Together, OZMOSI and Planview are redefining how pharmaceutical organizations approach R&D strategy, ensuring that investment decisions are guided by accurate, standardized, and AI-ready data. By combining internal portfolio visibility with a continuously updated external view of the market, the partnership helps leaders not only understand what they have, but what to do next.

About OZMOSI

Founded in 2013, OZMOSI specializes in transforming complex pharmaceutical R&D intelligence into structured, machine-readable data. The company provides the foundation needed for accurate competitive analysis, product forecasting, and portfolio strategy. Through its proprietary taxonomy and semantic layer, OZMOSI connects fragmented data across the pharmaceutical ecosystem, enabling faster, more confident decision-making for global pharma, biotech, and investment teams.

Based in Spring Lake Heights, New Jersey, OZMOSI is focused on making pharmaceutical intelligence clear, usable, and ready for the future of AI-driven strategy. Learn more at www.ozmosi.com.

About Planview

Planview is the leading end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD), powered by advanced AI capabilities that give business and technology leaders the strategic foresight to prioritize investments and initiatives, make plans real within constraints, and pivot with certainty when things change. Our AI-driven connected platform of solutions underpins the business and digital transformations of more than 3,000 customers and 3.1 million users globally. Headquartered in Austin, Texas, Planview has over 1,500 employees worldwide. Learn more at www.planview.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ozmosi-announces-strategic-partnership-with-planview-to-advance-ai-driven-planning-in-pharmaceutical-rd-302750944.html

SOURCE Ozmosi Company

Continue Reading

Trending